€2.82
2.17% today
Xetra, Apr 01, 05:36 pm CET
ISIN
DE000A11QVV0
Symbol
HPHA
Index
Sector
Industry

Heidelberg Pharma Stock price

€2.82
+0.16 6.02% 1M
+0.51 22.08% 6M
+0.38 15.57% YTD
-0.30 9.62% 1Y
-2.78 49.64% 3Y
-3.18 53.00% 5Y
-0.04 1.47% 10Y
Xetra, Closing price Tue, Apr 01 2025
+0.06 2.17%
ISIN
DE000A11QVV0
Symbol
HPHA
Index
Sector
Industry

Key metrics

Market capitalization €128.62m
Enterprise Value €121.17m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 17.69
P/S ratio (TTM) P/S ratio 18.78
P/B ratio (TTM) P/B ratio 4.17
Revenue growth (TTM) Revenue growth -30.53%
Revenue (TTM) Revenue €6.85m
EBIT (operating result TTM) EBIT €-23.51m
Free Cash Flow (TTM) Free Cash Flow €-30.04m
Cash position €29.42m
EPS (TTM) EPS €-0.42
P/E forward negative
P/S forward 13.98
EV/Sales forward 13.17
Show more

Is Heidelberg Pharma a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,804 stocks worldwide.

Heidelberg Pharma Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a Heidelberg Pharma forecast:

2x Buy
100%

Analyst Opinions

2 Analysts have issued a Heidelberg Pharma forecast:

Buy
100%

Financial data from Heidelberg Pharma

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Nov '24
+/-
%
6.85 6.85
31% 31%
100%
- Direct Costs 2.65 2.65
36% 36%
39%
4.20 4.20
27% 27%
61%
- Selling and Administrative Expenses 5 5
43% 43%
73%
- Research and Development Expense 22 22
22% 22%
319%
-23 -23
12% 12%
-331%
- Depreciation and Amortization 0.87 0.87
1% 1%
13%
EBIT (Operating Income) EBIT -24 -24
12% 12%
-343%
Net Profit -19 -19
5% 5%
-283%

In millions EUR.

Don't miss a Thing! We will send you all news about Heidelberg Pharma directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Heidelberg Pharma AG is a holding company, which engages in the development of diagnostic and therapeutic oncology products for the detection and targeted treatment of various types of cancer. It operates through the following segments: Customer Specific Research, Diagnostics, and Therapeutics. The company was founded by Olaf G. Wilhelm, Manfred Schmitt, Viktor Magdolen, Heinrich Graeff, Bernd Gänsbacher, Horst Kessler, Peter Nawroth, and Thomas Luther in September 1997 and is headquartered in Ladenburg, Germany.

Head office Germany
CEO Andreas Pahl
Employees 116
Founded 1997
Website heidelberg-pharma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today